Doximity, Inc.

NYSE:DOCS

Medical - Healthcare Information Services

Healthcare
$30.67 -0.44%

-$0.09 today

Market cap
$5.47B
Beta
1.29
P/E (TTM)
19.2
EPS (TTM)
$1.06
52W Low $17.15High $76.51

Volume 2.27M

Average 3.89M

DOCS EBITDA Margin

EBITDA as a percentage of revenue.

Doximity, Inc.NYSE: DOCS

EBITDA Margin · Q2 FY2027 · quarter ended Sep 2026

EBITDA Margin narrows to 25.2%

EBITDA Margin was 25.2% in Q2 FY2027, down 20.2 pp from a year earlier. On a trailing-twelve-month basis it was 31.7%, down 16.1 pp year over year. Over 3 fiscal years it widened by 6.8 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 15 analysts of 45.6% for the fiscal year ending Mar 2027, up from 41.0% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
25.2%-3.3 pp QoQ
Last fiscal yearMar 2026
41.0%-1.2 pp YoY
LTMSep 2026
31.7%-16.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-20.2 pp+5.9 pp+26.1 pp
1 year-1.2 pp+4.6 pp+5.8 pp
3 years+6.8 pp+8.1 pp+1.4 pp
5 years+15.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2026
41.0%
Year-over-year change
-1.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How DOCS compares with its peers on the latest reported figures

  • DOCS's LTM Sep 2026 EBITDA Margin of 31.7% is the 2nd highest of the 10 companies compared; the peer median is 21.5%.
  • Its year-over-year change of -16.1 pp is the lowest of 10, against a peer median of +1.1 pp.
  • Over three fiscal years its change of +6.8 pp compares with a peer median of +2.7 pp.
DOCS Competitors Peer median
EBITDA Margin for DOCS and competitors
Company Period LTM level YoY 3-year change
HQYHealthEquity, Inc.LTM Jul 202636.3% +4.4 pp+17.3 pp
DOCSDoximity, Inc.LTM Sep 202631.7% -16.1 pp+6.8 pp
SOLVSolventum CorporationLTM Jun 202629.7% +14.5 pp+2.7 pp
RVTYRevvity, Inc.LTM Jul 202626.3% -3.0 pp-8.9 pp
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
COOThe Cooper Companies, Inc.LTM Jul 202621.5% -5.5 pp-0.8 pp
VTRSViatris Inc.LTM Jun 202618.4% +21.9 pp-42.3 pp
ICLRICON Public Limited CompanyLTM Jun 202615.1% -1.9 pp-7.7 pp
TEMTempus AI, Inc.LTM Sep 2026-7.2% +1.0 pp+64.5 pp
GHGuardant Health, Inc.LTM Sep 2026-34.5% +4.7 pp+98.7 pp
Peer median (excluding DOCS) 21.5%+1.1 pp+2.7 pp

Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue343.55M419.05M475.42M570.4M644.86M
Cost of Revenue39.79M53.49M50.67M55.87M70.33M
Gross Profit303.76M365.56M424.75M514.53M574.54M
Gross Margin88.4%87.2%89.3%90.2%89.1%
Research & Development62.35M80.19M81.98M93.04M130.7M
Selling, General & Admin127.88M160.27M170.96M191.38M228.92M
Operating Expenses190.23M240.45M260.88M286.73M359.62M
Depreciation & Amortization5.04M10.28M10.27M10.66M14.38M
EBITDA119.05M143.44M182.08M240.76M264.39M
EBITDA Margin34.7%34.2%38.3%42.2%41.0%
Operating Income113.54M125.11M163.88M227.8M214.92M
Operating Margin33.0%29.9%34.5%39.9%33.3%
Interest Income2.15M9.29M21.66M35.85M35.7M
Interest Expense00000
Other Income / Expenses469K8.05M21.32M35.77M35.09M
Income Before Tax114.01M133.16M185.2M263.57M250.01M
Pre-Tax Margin33.2%31.8%39.0%46.2%38.8%
Income Tax Expense(40.78M)20.34M37.62M40.39M53.95M
Net Income154.78M112.82M147.58M223.19M196.05M
Net Margin45.1%26.9%31.0%39.1%30.4%
EPS (Basic)0.810.580.781.191.05
EPS (Diluted)0.700.530.721.110.98
Weighted Avg Shares163.48M193.18M190.17M186.84M187.01M
Weighted Avg Shares (Diluted)191.02M213.43M205.73M201.21M199.05M

Doximity, Inc.

NYSE:DOCS

Intrinsic Alpha fair value

Locked

Current Price

$30.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.